Jayme M Heim, MSN, FNP-BC

Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Videos

I'm sorry, it seems there is no article text provided for me to summarize and analyze. Please provide the text of the article, and I'll be happy to assist you

Lauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.

Exploring Oral Systemic Therapies For Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Podcasts

Focusing in on Novel Oral Systemic Therapies for Moderate Plaque Psoriasis: Medcast Video

03:15 The role of APP’s in getting patients access to dermatological care.

06:06 Managing patients with suboptimal controlled plaque psoriasis

13:05 Breaking down barriers to access new treatments for plaque psoriasis.

20:23 Deciding between oral and injectable systemic therapies.

24:25 The mechanism of action of TYK-2 inhibitors

28:24 The safety profile of deucravacitinib

33:14 Monitoring your patients with plaque psoriasis

Lauren Miller, MPAS, PA-C, leads an expert discussion surrounding exciting developments in the treatment landscape of plaque psoriasis.

developments in the treatment landscape of plaque psoriasis, novel oral systemic treatment options to alleviate the burden of this chronic disease.

A Patient-Centric Medcast on the Journey Through Moderate Plaque Psoriasis

07:48 Absence of treatment or under treatment of plaque psoriasis

12:50 Prescribing novel systemic medications in plaque psoriasis as an advanced practice provider

15:46 Classifying moderate disease in plaque psoriasis

19:43 Getting payer approval for your patients with plaque psoriasis

23:18 Novel oral systemic treatments for plaque psoriasis

25:03 Pivotal clinical trial data on deucravacitinib

27:58 Deciding on aprimilast versus deucravacitinib for your patients with plaque psoriasis

31:53 Mechanism of action of deucravacitinib

38:13 Selecting a therapy in the evolving treatment landscape for your patient with plaque psoriasis

43:08 Educating your patients on injectables and orals systemic treatments

Advanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.

Jayme M Heim, MSN, FNP-BC

Articles